SCHEMBL22889402

SCHEMBL22889402

c1ccc(-c2ccc3ccc(-c4ccc(-c5nc(-c6ccc(-c7ccccc7)c7ccccc67)nc(-c6cccc7c6oc6ccccc67)n5)c5ccccc45)cc3c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.49
GGPS1 O95749 1/20 0.40
PRKDC P78527 5/20 0.38
PTGES2 Q9H7Z7 1/20 0.38
PIM1 P11309 1/20 0.36
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CB P42338 1/20 0.36
PGR P06401 1/20 0.36
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
MAPT P10636 2/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889392 0.98 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2PIM1
SCHEMBL26251886 0.96 ALOX5 (0.45) ALOX5GGPS1PRKDCPTGES2PIM1
SCHEMBL22889398 0.95 ALOX5 (0.45) ALOX5GGPS1PRKDCPTGES2PIM1
SCHEMBL26251941 0.95 ALOX5 (0.45) ALOX5GGPS1PRKDCPTGES2PIM1
SCHEMBL22889007 0.95 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2PIM1
SCHEMBL22888623 0.95 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2PIK3CD
SCHEMBL26251943 0.94 ALOX5 (0.44) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL22889427 0.94 ALOX5 (0.44) ALOX5GGPS1PRKDCPTGES2PIM1
SCHEMBL22889274 0.94 ALOX5 (0.43) ALOX5GGPS1PRKDCPTGES2PIM1
SCHEMBL26251736 0.94 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885GGPS1 3177/4885PRKDC 4797/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885GGPS1 3231/4885PRKDC 4796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.